药物信息为ENBREL (etanercept) For Subcutaneous Injection (Immunex Corp): OVERDOSAGE
- DESCRIPTION
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- OVERDOSAGE
- HOW SUPPLIED
- REFERENCES
- Medication GuideENBREL® (en-brel)(etanercept)
- Patient Instructions for UseENBREL® (en-brel)(etanercept)Single-use Prefilled Syringe
- Patient Instructions for UseENBREL® (en-brel)(etanercept)Multiple-use Vial
- Patient Instructions for UseENBREL® (en-brel)(etanercept)Single-use Prefilled SureClick™ Autoinjector
- PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - PREFILLED SYRINGE, 25 MG
- PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - PREFILLED SYRINGE, 50 MG
- PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - PREFILLED AUTOINJECTOR, 50 MG
- PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - VIAL, 25 MG
- 外部链接相关的ENBREL (etanercept) For Subcutaneous Injection (Immunex Corp)
The maximum tolerated dose of ENBREL® has not been established in humans. Toxicology studies have been performed in monkeys at doses up to 30 times the human dose with no evidence of dose-limiting toxicities. No dose-limiting toxicities have been observed during clinical trials of ENBREL®. Single IV doses up to 60 mg/m2 have been administered to healthy volunteers in an endotoxemia study without evidence of dose-limiting toxicities.
- Drug Information Provided by National Library of Medicine (NLM).
